These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 15924831)

  • 41. Benefit of pegylated interferon-alpha-2a/ribavirin in a patient with common variable immunodeficiency and hepatitis C virus cirrhosis after liver transplantation and splenic embolization.
    Foruny JR; Bárcena R; Moreno A; Blázquez J; Manzano R; Gil-Grande LA; Moreno A; Nuño J
    Transplantation; 2006 Jul; 82(2):289-90. PubMed ID: 16858295
    [No Abstract]   [Full Text] [Related]  

  • 42. The treatment of viral hepatitis, present and future.
    Rodés J
    J Hepatobiliary Pancreat Surg; 2003; 10(2):163-7. PubMed ID: 14505150
    [No Abstract]   [Full Text] [Related]  

  • 43. [Protocol for the antiviral therapy of hepatitis C].
    Judit G; Gábor H; Béla H; Mihály M; Alajos P; Ferenc S; István T; László T; ;
    Orv Hetil; 2010 Jan; 151(2):66-72. PubMed ID: 20061235
    [No Abstract]   [Full Text] [Related]  

  • 44. Peginterferon and ribavirin for hepatitis C.
    Abramowicz M
    N Engl J Med; 2007 Mar; 356(12):1270-1; author reply 1271. PubMed ID: 17378100
    [No Abstract]   [Full Text] [Related]  

  • 45. [Treatment of hepatitic C virus infection after the French 2002 Consensus Conference].
    Cacoub P
    Rev Med Interne; 2002 Nov; 23(11):889-92. PubMed ID: 12481388
    [No Abstract]   [Full Text] [Related]  

  • 46. Acquired factor VIII inhibitor in an HIV-infected patient after treatment with pegylated interferon-alpha 2a and ribavirin.
    Paul S; Javed U; Tevendale R; Lanford J; Liu R
    AIDS; 2007 Mar; 21(6):784-5. PubMed ID: 17413709
    [No Abstract]   [Full Text] [Related]  

  • 47. The multifaceted functions of ribavirin: antiviral, immunomodulator, or both?
    Mondelli MU
    Hepatology; 2014 Oct; 60(4):1126-9. PubMed ID: 24753082
    [No Abstract]   [Full Text] [Related]  

  • 48. Acute exacerbation among chronic hepatitis C patients: tip of the iceberg that deserves more attention.
    Wong RJ; Cheung RC
    Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1181-2. PubMed ID: 23735449
    [No Abstract]   [Full Text] [Related]  

  • 49. Combination therapy for hepatitis C infection.
    Newman TB
    N Engl J Med; 1999 Apr; 340(15):1207; author reply 1208-9. PubMed ID: 10206843
    [No Abstract]   [Full Text] [Related]  

  • 50. Management of hepatitis C.
    Sjogren MH
    Gastroenterology; 2006 Jul; 131(1):332; author reply 332-3. PubMed ID: 16831622
    [No Abstract]   [Full Text] [Related]  

  • 51. HCV infection in the setting of HIV: prevalence, disease, treatment.
    Laurence J
    AIDS Read; 2006 Mar; 16(3):115-6. PubMed ID: 16538952
    [No Abstract]   [Full Text] [Related]  

  • 52. Treatment of recurrent hepatitis C.
    Gane E
    Liver Transpl; 2002 Oct; 8(10 Suppl 1):S28-37. PubMed ID: 12362295
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Adverse effects of combining polyethylene glycol interferon with ribavilin on hepatitis C patients].
    Si CW
    Zhonghua Gan Zang Bing Za Zhi; 2003 Nov; 11(11):686-7. PubMed ID: 14636449
    [No Abstract]   [Full Text] [Related]  

  • 54. Long term suppressive therapy with pegylated interferon for chronic hepatitis C associated membranoproliferative glomerulonephritis.
    Cua IH; Kwan V; Henriquez M; Kench J; George J
    Gut; 2006 Oct; 55(10):1521-2. PubMed ID: 16966706
    [No Abstract]   [Full Text] [Related]  

  • 55. Digestive Disease Week 2000 conference report: New treatments for chronic hepatitis C.
    Brown PJ; Neuman MG
    Can J Clin Pharmacol; 2001; 8(2):67-71. PubMed ID: 11493933
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Primer treatment of acute and chronic hepatitis C].
    Daruich J; Fainboim H; Frider B
    Acta Gastroenterol Latinoam; 2006 Jun; 36 Suppl 1():S52-6; discussion S74-82. PubMed ID: 16862862
    [No Abstract]   [Full Text] [Related]  

  • 57. [ANRS HC 02 RIBAVIC: from multicenter trial to daily practice].
    Pol S
    Gastroenterol Clin Biol; 2009 Mar; 33 Suppl 2():S91-3. PubMed ID: 19375041
    [No Abstract]   [Full Text] [Related]  

  • 58. A view to natural killer cells in hepatitis C.
    Shoukry NH; Pelletier S; Chang KM
    Gastroenterology; 2011 Oct; 141(4):1144-8. PubMed ID: 21875586
    [No Abstract]   [Full Text] [Related]  

  • 59. Peginterferon and ribavirin for hepatitis C.
    Duggan AE; Duggan JM
    N Engl J Med; 2007 Mar; 356(12):1269; author reply 1271. PubMed ID: 17377169
    [No Abstract]   [Full Text] [Related]  

  • 60. Successful treatment with peginterferon and ribavirin in a patient with acute hepatitis C evolving into chronicity.
    Hsieh TH; Kao JH; Lai MY; Chen PJ; Chen DS
    J Formos Med Assoc; 2005 May; 104(5):354-8. PubMed ID: 15959603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.